Evidence map›Paper›PMID 30327714›Full record

ArticleOxidative medicine and cellular longevity2018

Reduced Susceptibility to Sugar-Induced Metabolic Derangements and Impairments of Myocardial Redox Signaling in Mice Chronically Fed with D-Tagatose when Compared to Fructose.

Debora Collotta, Laura Lucarini, Fausto Chiazza, Alessia Sofia Cento, Mariaconcetta Durante, Silvia Sgambellone, Jacopo Chini, Francesca Baratta, Manuela Aragno, Raffaella Mastrocola and 2 more

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Oxidative medicine and cellular longevity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Role ofAntioxidants (Basel, Switzerland) · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. KRIT1 Deficiency Promotes Aortic Endothelial Dysfunction.International journal of molecular sciences · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Debora CollottaDepartment of Drug Science and Technology, University of Turin, Italy.
Laura LucariniDepartment of NEUROFARBA, University of Florence, Italy.
Fausto ChiazzaDepartment of Drug Science and Technology, University of Turin, Italy.
Alessia Sofia CentoDepartment of Clinical and Biological Sciences, University of Turin, Italy.
Mariaconcetta DuranteDepartment of NEUROFARBA, University of Florence, Italy.
Silvia SgambelloneDepartment of NEUROFARBA, University of Florence, Italy.
Jacopo ChiniInalco RSM S.p.a, Research Center, Montale, Pistoia, Italy.
Francesca BarattaDepartment of Drug Science and Technology, University of Turin, Italy.
Manuela AragnoDepartment of Clinical and Biological Sciences, University of Turin, Italy.
Raffaella MastrocolaDepartment of Clinical and Biological Sciences, University of Turin, Italy.ORCID 0000-0002-0104-6129
Emanuela MasiniDepartment of NEUROFARBA, University of Florence, Italy.
Massimo CollinoDepartment of Drug Science and Technology, University of Turin, Italy.ORCID 0000-0001-8782-3496
University of Turin · ITUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundD-tagatose is an isomer of fructose and is ~90% as sweet as sucrose with less caloric value. Nowadays, D-tagatose is used as a nutritive or low-calorie sweetener. Despite clinical findings suggesting that D-tagatose could be beneficial in subjects with type 2 diabetes, there are no experimental data comparing D-tagatose with fructose, in terms of metabolic derangements and related molecular mechanisms evoked by chronic exposure to these two monosaccharides. MATERIALS AND

methodsC57Bl/6j mice were fed with a control diet plus water (CD), a control diet plus 30% fructose syrup (L-Fr), a 30% fructose solid diet plus water (S-Fr), a control diet plus 30% D-tagatose syrup (L-Tg), or a 30% D-tagatose solid diet plus water (S-Tg), during 24 weeks.

resultsBoth solid and liquid fructose feeding led to increased body weight, abnormal systemic glucose homeostasis, and an altered lipid profile. These effects were associated with vigorous increase in oxidative markers. None of these metabolic abnormalities were detected when mice were fed with both the solid and liquid D-tagatose diets, either at the systemic or at the local level. Interestingly, both fructose formulations led to significant Advanced Glycation End Products (AGEs) accumulation in mouse hearts, as well as a robust increase in both myocardial AGE receptor (RAGE) expression and NF-

conclusionOur results clearly suggest that chronic overconsumption of D-tagatose in both formulations, liquid or solid, does not exert the same deleterious metabolic derangements evoked by fructose administration, due to differences in carbohydrate interference with selective proinflammatory and oxidative stress cascades.

Indexed as

AnimalsFructoseHeartHexosesMaleMetabolic SyndromeMiceMice, Inbred C57BLMyocardiumOxidation-ReductionOxidative StressRandom AllocationSignal TransductionSweetening AgentsFructoseHexosesSweetening Agentstagatose

Identifiers

PMID30327714
PMCPMC6169220
OpenAlexW2891501090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.